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ABSTRACT
Background: Increasing interest in empirical ethics has
enhanced understanding of healthcare professionals’
ethical problems and attendant decision-making. A four-
stage decision-making model involving ethical attention,
reasoning, intention and action offers further insights into
how more than reasoning alone may contribute to
decision-making.
Aims: To explore how the four-stage model can increase
understanding of decision-making in healthcare and
describe the decision-making of an under-researched
professional group.
Methods: 23 purposively sampled UK community
pharmacists were asked, in semi-structured interviews, to
describe ethical problems in their work and how they
were resolved. Framework analysis of transcribed inter-
views utilised the four decision-making stages, together
with constant comparative methods and deviant-case
analysis.
Results: Pharmacists were often inattentive and con-
structed problems in legal terms. Ethical reasoning was
limited, but examples of appeals to consequences, the
golden rule, religious faith and common-sense experience
emerged. Ethical intention was compromised by frequent
concern about legal prosecution. Ethical inaction was
common, typified by pharmacists’ failure to report
healthcare professionals’ bad practices, and ethical
passivity emerged to describe these negative examples of
the four decision-making stages. Pharmacists occasionally
described more ethically active decision-making, but this
often involved ethical uncertainty.
Discussion: The four decision-making stages are a useful
tool in considering how healthcare professionals try to
resolve ethical problems in practice. They reveal
processes often ignored in normative theories, and their
recognition and the emergence of ethical passivity
indicates the complexity of decision-making in practice.
Ethical passivity may be deleterious to patients’ welfare,
and concerns emerge about improving pharmacists’
ethical training and promoting ethical awareness and
responsibility.
Individuals working within healthcare face ever
more ethical problems and although normative
ethical theories offer guidance as to how such ethical
problems should be resolved, in practice ethical
decision-making may be a complex, variable and
difficult process. This disjuncture between normative
ethical ideals and the reality of healthcare practice
has led to concerns regarding the relevance of
normative approaches1 and there has been a burgeon-
ing interest in empirical ethics, which offers increas-
ed understanding of the ethical problems encoun-
tered by individuals in healthcare and attendant
decision-making.2 In contrast to normative theories
that champion reasoning alone, empirical insights
recognise how difficult ethical decision-making can
be in practice, and this is no more evident than in the
development of ethical decision-making models that
recognise several distinct stages of decision-making in
practice. Various decision-making models have been
proposed,3 often in a business ethics context and
originally serving positivistic aims of explaining and
predicting behaviour,4 but these have been argued to
be relevant to healthcare ethics.5 A central feature of
many models is a four-stage process of decision-
making that was originally proposed by Rest,6
involving ethical reasoning and also recognising an
ethical problem, intending to act ethically and
overcoming self-interest and, finally, acting ethically
and implementing what one has decided is the
ethically correct decision (figure 1).
Here we present the findings of a study in which
these four stages were used to explore how a
sample of UK community pharmacists made
ethical decisions. Pharmacists were chosen because
they have been relatively under-researched in
relation to ethics7 and also because their ethical
reasoning and understanding may be relatively
limited8 and legalistic9 and may be particularly
suited to empirical decision-making models that
admit of more than reasoning alone. Previous
empirical research has framed pharmacists’ reason-
ing in terms of ethical theory such as the four
principles of bioethics, but only scant10 or infer-
ential11 evidence of such normatively informed
reasoning emerged. The four-stage model originally
developed by Rest was also informed by normative
theory—cognitive moral development—but this
research follows the approach used by Holm,5 in
rejecting any definitive normative theory but being
informed by the four stages conceptually. The aim
was to use the four-stage model to sensitise the
question guides for, and the subsequent analysis of,
pharmacists’ interviews about ethical problems
and their resolution, while maintaining an inter-
pretative methodology that valued the possible
complexity and variation in actual ethical practice.
It will be argued from the results of the study,
however, that pharmacists could more often be
described in terms of omissions or deficiencies in the
four stages, and the term ethical passivity is devel-
oped, to describe pharmacists who were ethically
inattentive, who displayed limited forms of reason-
ing, prioritised legalistic self-interest and could not
act. Such passivity is argued to be inimical to
healthcare practice and may be detrimental both to
the welfare of patients and for pharmacy.
Figure 1 Stages of decision-making.
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METHODS
As part of a larger study concerned with ethical problems,
decision-making and the influence of the community pharmacy
environment, semi-structured qualitative interviews were used,
to allow pharmacists to describe, in their own words, ethical
problems and how they tried to resolve them. This method also
permitted the researcher to clarify responses and to prompt
pharmacists about particular areas of pharmacy practice and
encourage them to explore their decision-making. This was
underpinned methodologically by an interpretative approach
that valued pharmacists’ construction of ethical problems and
their decision-making, and also the role of the researcher in
interpreting and shaping this construction. As such, the use of
the four stages represented a loose analytical framework and
was not considered definitive.5 An interview guide was
developed that included questions such as
c ‘‘Could you describe an ethical issue in your work?’’
c ‘‘What were the relevant features that made it ethical?’’
c ‘‘How did you try to resolve the ethical issue?’’
Twenty-three UK pharmacists were recruited from two
counties in northern England, through a combination of
contacts of the researcher, opportunistic approaches and
purposive sampling to obtain representation in terms of age,
gender, ethnicity and employment status. The sample size was
also determined by theoretical saturation being reached when
no further themes emerged from interviews. Relevant ethics
committee approval was obtained for this study from the
University of Nottingham School of Pharmacy. Non-participa-
tion was common, and reasons cited for it included not being
able to recall an ethical problem or being too busy at work. All
but three pharmacists agreed to interviews being recorded, and
these were then fully transcribed. In the non-recorded inter-
views, extensive notes were taken, and interviews averaged
50 min in duration. Framework analysis of transcribed inter-
views was undertaken using the four stages of decision-making,
together with the constant comparative process. All emergent
themes were coded and deviant-case analysis was also under-
taken to inform further samples. Pseudonyms are used to
protect anonymity.
RESULTS
Even before framework analysis of interviews was undertaken,
it was apparent that pharmacists seemed to be unused to, and
uncomfortable with, talking about ethical problems and
decision-making. Analysis of interviews using the four stages
revealed that the responses of many pharmacists could be
considered negatively, in terms of omissions or inadequacies of
the four decision-making stages. Occasional examples did
emerge of pharmacists who appeared to be describing a
particular stage of decision-making, but this was seldom
accompanied by a sustained decision-making process involving
all four stages. Each of the four stages is now considered in turn
and examples are provided of where pharmacists did not appear
to use the stages of decision-making. Counter-examples are
indicated, where appropriate, of pharmacists who did appear to
use a stage of decision-making.
Ethical attention
Pharmacists described a number of what they perceived to be
ethical problems in their work, although these seldom involved
rival value conflicts and were frequently procedural or legal
conflicts, originating in the routine minutiae of community
pharmacy practice; they are reported elsewhere.9 It was
apparent that many pharmacists found it very difficult to recall
ethical issues in their work, and this combination of a legalistic
and procedural construction of problems, coupled with a
marked inability to identify and recount ethical problems, led
to many interviews being difficult to conduct, because it was
difficult to elicit pharmacists’ examples and reasoning about
ethical problem. This inability to identify ethical issues or
ethically relevant aspects of problems led to the emergence of
ethical inattention as an appropriate description of many
pharmacists and was the first indication of ethical passivity.
Paradoxically, such inattention did not prevent some pharma-
cists claiming to be ethically confident, despite not recognising
ethical problems:
Pharmacist: You don’t realise that it’s an ethical issue that you’re
dealing with and you just deal with it everyday, yea. So, yea, I
think that was it…
Interviewer: Do you think you’re doing things correctly, in an
ethical way? …
Pharmacist: Yes, I would say that I was dealing with them
ethically.
Interviewer: Even though you might not perhaps be aware of
them?
Pharmacist: That’s right, yea
In contrast, a minority of pharmacists described ethical
problems more readily and in more detail, but such pharmacists
also described an attendant ethical doubt and uncertainty. Being
able to see what was ethical did not lead to ethical confidence
for such pharmacists, and they described not knowing what to
do and, like many pharmacists in this study, often referred to
the threat of prosecution or disciplinary action.
It was apparent that interviews offered pharmacists an
opportunity—and for some the first ever opportunity—to
consider and discuss what might be ethical. This post hoc
reconstruction of ethical events and details appeared to indicate
that little reflection on ethical decision-making and problems
had occurred in practice for many, as one pharmacist conceded
about ethical issues:
In fact there’s probably loads but until you actually sit and think
about them.
Ethical reasoning
Pharmacists were asked about their reasoning and justification
for decisions, and it was apparent that again, as when trying to
describe ethical problems, many found this a very difficult task;
it seemed that this was something they had not done before.
There was a lack of articulacy about value concepts, but
analysis of interviews did reveal several broad areas of reasoning,
and examples of appeals to consequences, the golden rule,
common-sense experience and religion emerged. Pharmacists
were also asked if their training or ethical codes were influential
or helpful, but these were summarily dismissed by almost all
pharmacists as being of little value in their work.
Appeals to the consequences of an action were the most
frequently identified reasoning, but such justification was often
limited; pharmacists did not, for example, include a compre-
hensive assessment of consequences for other possible indivi-
duals and it was frequently only the patient who was
considered. It was also apparent that the value of utility
referred to in relation to consequences was often the ‘‘best
interests’’ of the patient—a legal term that pharmacists could
not explain further. The golden rule was also used as a form of
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ethical reasoning by several pharmacists and involved them
reflecting upon their decisions in terms of how they or their
relatives would feel if they were the recipient of the decision.
This was typified by one pharmacist, when explaining why he
helped a patient who was being prevented from speaking to her
doctor by the surgery:
… how would you feel if that was your mother, father, being
treated like that? And that’s the way I try and think of it, what
service would you want? … How would you feel and how would
you want to be treated … I’m not saying I’d break the law or
bend rules, you know what I mean, but always try to take their
[point of view …]
This quote also indicates the tension between legal and ethical
considerations and that, for almost all the pharmacists, a legal
consideration was usually important, too.
The role of experience and common sense appeared to be
significant for many pharmacists in explaining how ethical
decisions were made. This was valued above undergraduate
ethics training or the code of ethics but, unfortunately, there
was a marked difficulty in further explaining or exploring this
experiential approach, as Sharon noted:
It’s difficult because with ethics, I feel it’s something that you
learn in your job—you don’t really learn it at university. You can
be given all these things, all these scenarios, but really you need
to put them into actual practice and then you sort of use your
gut instinct.
Religion also appeared to be important in the reasoning and
justification of a minority of pharmacists, although others
argued that religious faith was not relevant to pharmacy work.
What was striking in the case of those who used religious
justification was the unconditional nature of such reasoning, to
the exclusion of other factors, and as Christopher explained:
Every kind of moral or ethic that I’m faced with, ultimately,
comes back to my Christian experience and I’d measure it against
my Christian value—whatever it was.
The sale of emergency hormonal contraception (EHC) was
especially problematic for such pharmacists, and it was religion
that underpinned their decisions not to sell such medicines and
led to their belief that it was a form of abortion. However, as
will be seen in discussion of the fourth stage, ethical passivity
due to a sense of subordination led such pharmacists to
continue dispensing EHC, because a doctor was considered
superior and ultimately responsible.
Other forms of reasoning did emerge, although these were
infrequent and included implicit appeals to autonomy, although
pharmacists never used the actual word. Pharmacy customers
were often cited, and several pharmacists argued that they
should not be prevented from purchasing medicines and
pharmacists were resigned to merely giving advice or warnings.
However, when appeals to autonomy were made, they did not
appear to involve any balancing with rival values or principles.
Three pharmacists referred to the broader social background
of patients, and their reasoning involved relatively detailed
narratives of patients and customers; but among the sample in
this study, such sensitivity and attention to the wider context
of ethical decision-making were rare.
Ethical intention
The third stage of empirical decision-making involves intending
to act, and overcoming concerns such as self-interest. However,
what was striking among almost all the pharmacists inter-
viewed was concern about legal prosecution or disciplinary
action in relation to how an ethical problem should be dealt
with, as Sharon illustrated:
I do try and look after the patient’s best interests but I won’t put
my certificate on the line. I won’t do anything that the law says
that I shouldn’t be doing, you know what I mean? ... More
covering myself, yea, rather than looking after the patient. That’s
terrible. It’s not terrible but it’s looking after myself.
In this stage, it was apparent that pharmacists had identified
an ethical problem or a value therein but had prioritised their
own interests and, in particular, the threat of legal prosecution
or disciplinary action. While this was a common concern for
pharmacists, occasional examples of ethics trumping law were
mentioned, and in one example a pharmacist argued that a
doctor’s genuine mistake in prescription writing should not
mean denying patients necessary medicines.
Ethical action
The final, empirical decision-making stage involves acting
upon what one has decided, and it emerged that many
pharmacists were unable at times to do what they believed
they should do and that when this happened they simply did
nothing or allowed supervening acts or the intervention of
others to resolve the situation. An example of this was
pharmacists’ observations of what they believed to be
unacceptable standards or practices of other healthcare
professionals—doctors, nurses and pharmacists. When
prompted, the pharmacists admitted that they should have
done something but did nothing and, furthermore, often
recognised that their inaction might have perpetuated the
problem and even could have resulted in harm. Specific
examples included not challenging a local doctor’s repeated
prescribing of medicines that could interact dangerously, not
fully reporting suspected sexual harassment, not reporting a
nurse who was suspected of being under the influence of
alcohol while working and, in the following example, not
offering assistance to a police enquiry that involved an appeal
for information about a criminal suspect who was known to
the pharmacist as a patient:
I think eventually they caught him anyway so I didn’t actually
have to do that [identify the patient]. It was very convenient in
the end, yes, but I did sweat on it for a week or two. So in a way I
suppose that was shirking my responsibilities. Was that ethical? I
don’t know.
Pharmacists’ ethical passivity was also apparent in allowing
others to resolve ethical situations: in the above example of a
nurse suspected of consuming alcohol at work the pharmacist
admitted that her inability to act meant that the nurse
continued to work and posed a possible threat to patients’
safety, and that it was only the intervention of another nurse
that brought the situation to light. As noted earlier, the example
of EHC and pharmacists’ apparent subordination to doctors also
indicated ethical passivity, as pharmacists admitted avoiding the
need to confront an ethical problem—dispensing EHC—by
shifting ethical responsibility to the prescribing doctor, as when
Christopher claimed:
I’m just a tool of the doctor really. I’m not happy with it, I’m
passing the buck and not accepting the responsibility that I
should be taking.
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DISCUSSION
Considering community pharmacists’ ethical decision-making
in terms of four distinct stages was intended to reveal how
variable and complex decision-making approaches may be in
healthcare. However, the emergence of predominantly negative
examples of decision-making and the emergence of ethical
passivity gives a rather bleak account of the pharmacists
sampled. Before considering the implications of such passivity
for pharmacists and healthcare, several possible concerns must
be addressed. First, it may be argued that instead of describing
pharmacists’ attempts at decision-making as being merely
sensitised by the four stages, the research invited direct
comparison. This appears to have elevated the four stages to
more than a loose analytical framework and to represent
another example of pharmacists’ ethical experiences being
compared with theory. Addressing this concern, it is argued
that the four stages are relatively uncontested as regards their
significance and that, furthermore, the research was sensitive to
other possible strategies but that little emerged from the
interviews. However, it was also in comparing the occasional
examples of some pharmacists’ more active ethical approach
with the predominantly negative examples that our awareness
of passivity emerged, since, although such instances were rare
and inconsistent, some pharmacists were at times ethically
attentive, overcame a fear of prosecution and acted decisively.
Hence, our emerging awareness of the ethical passivity among
pharmacists was at least in part a result of comparing
pharmacists’ responses, rather than of appealing to an objective
standard.
It is argued, however, that the four stages are relevant and
may be of value in considering how healthcare professionals try
to resolve ethical problems in practice. Despite being either
ignored or implied in the normative literature, ethical attention,
for example, has been argued to be significant as a step towards
ethical reasoning and also to be intrinsically valuable.12 For
Murdoch,13 ethical attention was not an isolated act, but rather
an attribute that allowed individuals to avoid difficult
instantiations of ethical choice. She distinguished between
attention and merely looking (echoing Merleau-Ponty’s use of
the term bemerken or simply noticing indiscriminately),14 and
this typified many pharmacists, who could recall situations that
were undoubtedly difficult but framed such problems, not in
terms of ethics or values, but of practical, legal or procedural
details. However, pharmacists who were more ethically
attentive could not avoid difficulty and uncertainty in their
decision-making, in contrast to Murdoch’s claim; this may be
because the interview process revealed only isolated instantia-
tions of attention and also because even attentive pharmacists
were still influenced by legal concerns and lacked sustained and
consistent reasoning. Furthermore, remaining open to the type
of reasoning also revealed insights that have been seldom
explored in the normative literature, and this was no more
apparent than in the case of the golden rule. Although often
considered a basic form of reasoning, its simplicity appeared to
be a strength and it was employed by several pharmacists.
Ethical intention has also been argued to be a relevant concern;
Maitland,15 for example, considers self-interest to be of relevance
in practice, but the manifestation of intention as self-interested
concern about legal prosecution is especially relevant. The
jurisprudential literature has often concentrated upon the
influence of ethics upon law, and philosophers usually acknowl-
edge the primacy of ethics; but, in practice, laws affect all
healthcare professionals and can lead to ethical and legal
conflicts for them.16 Including an ethical intention stage
highlights this conflict and offers further insights into the
practical difficulty of decision-making.
Ethical passivity does more than offer a bleak account of
pharmacists’ limited attempts to try to resolve ethical problems
in their work: it may also be detrimental to patients. In
particular, the fourth stage of ethical inaction revealed that
pharmacists’ inaction, by their own admission, could possibly
lead to harm. In the aftermath of incidents such as the Shipman
affair (in which suspicions about a general practitioner who
killed many of his patients were ignored or not followed up) in
the UK and increased awareness of the need to report
concerns,17 it is clear that the inability of healthcare profes-
sionals to act upon what they know to be professionally and
ethically wrong because of ethical passivity could lead to harm
to patients. Furthermore, pharmacists’ lack of ethical awareness
could result in their neither appreciating the ethical significance
of healthcare situations nor recognising even the needs of
patients in terms of values. Ethical passivity also appeared to
allow pharmacists to avoid ethical responsibility, and although
there may be occasions when someone more appropriate should
deal with a problem, many problems of healthcare ethics must
be resolved by individual practitioners. Gilligan18 used the image
of passivity to illustrate abdication of ethical responsibility but
argued that such passivity and inactivity might delay and also
worsen eventual ‘‘confrontations with choice’’. It is argued that
ethical passivity applied to healthcare could make problems in
practice even worse, to the potential detriment of patients, if
unethical or unprofessional practices continued or if patients’
ethical values were not recognised and respected.
Before we conclude, two study limitations must be addressed.
First, despite purposive sampling, these findings cannot
necessarily be generalised to other pharmacists or healthcare
professionals, although the empirical ethics literature does
contain descriptions of healthcare professionals—and especially
nurses—who appear to exhibit a similarly passive approach.
Deans19 described a sample of UK pharmacists as ‘‘not facing up
to problems or acting primarily from fear of disciplinary
procedures’’. In the nursing literature, Wurzbach20 noted that
nurses avoided ethical confrontation, and Omery (in a study
reported by Holm5) identified ‘‘accommodating’’ nurses who
could be characterised by avoidance and legalism. It may be no
coincidence that the emergence of such passive approaches to
ethical problems occurs in healthcare professions that have been
regarded as being subordinate,21 but further research may be
needed to explore this in relation to ethical responsibility.
Second, it is recognised that ethical passivity emerged in relation
to the problems that pharmacists described and it remains a
possibility that pharmacists might have used different decision-
making if given more dramatic hypothetical vignettes. Hence,
while it is argued that how healthcare professionals try to
resolve the problems they actually encounter is important in
understanding what occurs in practice, further research using
the four stages of decision-making and hypothetical scenarios
may yield further insights.
CONCLUSIONS
The use of an empirical model of decision-making offers the
possibility of exploring and describing more contextually how
healthcare professionals try to make ethical decisions in
practice, while being sensitive to the difficulty of such
decision-making. The emergence of ethical passivity presents a
formidable challenge for pharmacists and the pharmacy profes-
sion, raising questions about how ethics and values can be
effectively taught, communicated and applied in pharmacy
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practice, to avoid ethical passivity. Further research may be
necessary in other professions to explore the four stages and
consider whether ethical passivity occurs.
Competing interests: None.
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